Close
Nordic 9Nordic 9

Vida Ventures (investor - Venture Capital)

United States vidaventures.com
See something wrong or missing? Let us know
Offices:Boston
Average round investment:67.26M USD
Average number per year:2.0
Distribution: 2020 (2)
Portfolio companies: France InnoSkelNetherlands Neogene Therapeutics
Mostly invests in: France France (1) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Vida Ventures

Name Criteria
United States Bristol-Myers Squibb
69%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
Ireland Fountain Healthcare Partners
69%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
Belgium Gimv
69%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France, Netherlands
  • Average number of deals per year: 2.0
France Sanofi Ventures
69%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
Israel Pontifax Venture Capital
69%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
United States Cargill
69%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
France Creadev
69%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.2
Switzerland BioMedPartners
69%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.3
Hong Kong Horizons Ventures
69%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.4
Sweden IK Investment Partners
69%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.6
Top